Recursion Pharmaceuticals Inc. (RXRX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Recursion Pharmaceuticals...

    NASDAQ: RXRX · Real-Time Price · USD
    4.72
    0.09 (1.94%)
    At close: Sep 26, 2025, 3:59 PM
    4.72
    0.00%
    After-hours: Sep 26, 2025, 07:57 PM EDT

    Recursion Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 594.35M 391.56M 549.91M 285.12M
    Short-Term Investments
    		 n/a n/a n/a 231.45M
    Long-Term Investments
    		 n/a n/a 7.92M 8.68M
    Other Long-Term Assets
    		 14.45M 6.89M 7.92M 8.72M
    Receivables
    		 49.17M 3.09M 2.75M 9.09M
    Inventory
    		 n/a n/a 1.28M 1.55M
    Other Current Assets
    		 70.75M 43.48M 17.15M 9.07M
    Total Current Assets
    		 714.27M 438.14M 569.81M 534.72M
    Property-Plant & Equipment
    		 233.21M 120.17M 121.45M 64.72M
    Goodwill & Intangibles
    		 484.73M 88.5M 2.11M 2.19M
    Total Long-Term Assets
    		 734.33M 215.56M 131.47M 75.63M
    Total Assets
    		 1.45B 653.7M 701.29M 610.35M
    Account Payables
    		 21.61M 3.95M 4.59M 2.82M
    Deferred Revenue
    		 61.77M 36.43M 56.73M 10M
    Short-Term Debt
    		 22.22M 41K 6.05M 1.51M
    Other Current Liabilities
    		 81.87M 23.75M 14.48M 20.59M
    Total Current Liabilities
    		 187.47M 93.17M 100.27M 46.66M
    Long-Term Debt
    		 19.02M 1.1M 536K 633K
    Other Long-Term Liabilities
    		 190.75M n/a n/a 4.11M
    Total Long-Term Liabilities
    		 226.34M 97.09M 115.22M 20.75M
    Total Liabilities
    		 413.82M 190.26M 215.48M 67.41M
    Total Debt
    		 108.49M 50.67M 51.01M 11.48M
    Book Value
    		 1.03B 463.44M 485.81M 542.94M
    Book Value Per Share
    		 3.77 2.23 2.77 3.19
    Common Stock
    		 4K 2K 2K 2K
    Retained Earnings
    		 -1.43B -967.62M -639.56M -400.08M
    Comprehensive Income
    		 -7.64M n/a n/a -126K
    Shareholders Equity
    		 1.03B 463.44M 485.81M 542.94M
    Total Investments
    		 n/a 6.63M 7.92M 231.45M

    Add to Watchlist